Rivus Pharmaceuticals has a total of 45 patents globally, out of which 25 have been granted. Of these 45 patents, more than 95% patents are active. The USA is where Rivus Pharmaceuticals has filed the maximum number of patents, followed by Europe (EPO) and Japan. Parallelly, the United States seems to be the main focused R&D center of Rivus Pharmaceuticals and is also the origin country of the firm.
Rivus Pharmaceuticals was founded in the year 2019 by Allen Cunningham. The company operates as a biopharmaceutical firm dedicated to improving cardio-metabolic health.
Do read about some of the most popular patents of Rivus Pharmaceuticals which have been covered by us in this article and also you can find Rivus Pharmaceuticals patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Rivus Pharmaceuticals patent portfolio.
How many patents does Rivus Pharmaceuticals have?
Rivus Pharmaceuticals has a total of 45 patents globally. These patents belong to 6 unique patent families. Out of 45 patents, 43 patents are active.
How Many Patents did Rivus Pharmaceuticals File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Rivus Pharmaceuticals Applications Filed | Rivus Pharmaceuticals Patents Granted |
| 2022 | 3 | 16 |
| 2021 | 2 | 3 |
| 2020 | 2 | 1 |
| 2019 | 7 | 1 |
| 2018 | 28 | – |
How many Rivus Pharmaceuticals patents are Alive/Dead?
Worldwide Patents
How Many Patents did Rivus Pharmaceuticals File in Different Countries?
List of Countries in which Rivus Pharmaceuticals Filed Patents
| Country | Patents |
| United States Of America | 4 |
| Europe | 2 |
| Japan | 2 |
| Malaysia | 1 |
| Portugal | 1 |
| Norway | 1 |
| China | 1 |
| Slovenia | 1 |
| Colombia | 1 |
| Mexico | 1 |
| Denmark | 1 |
| Philippines | 1 |
| Eurasia | 1 |
| Singapore | 1 |
| Austria | 1 |
| Spain | 1 |
| Georgia | 1 |
| Malta | 1 |
| Hong Kong (S.A.R.) | 1 |
| Morocco | 1 |
| India | 1 |
| Peru | 1 |
| Indonesia | 1 |
| Poland | 1 |
| Israel | 1 |
| Saudi Arabia | 1 |
| Italy | 1 |
| Slovakia | 1 |
| Taiwan | 1 |
| South Africa | 1 |
Where are Research Centres of Rivus Pharmaceuticals Patents Located?
List of Rivus Pharmaceuticals Patents
| Rivus Pharmaceuticals Patents | Title |
| US10618875B2 | Phenyl Derivatives |
| US20210238144A1 | Phenyl Derivatives |
| MTP41656B | Novel Phenyl Derivatives |
| SKE39913T3 | New Phenyl Derivatives |
| SI3565806T1 | Novel Phenyl Derivatives |
| PL3565806T3 | Novel Phenyl Derivatives |
| ES2913431T3 | New Phenyl Derivatives |
| MA47210B1 | New Phenyl Derivatives |
| DK3565806T3 | New Phenyl Derivs |
| EP3565806B1 | Novel Phenyl Derivatives |
| IT202200032792T2 | New Phenylderivates. |
| NO3565806B1 | Novel Phenyl Derivatives |
| EP4086242A1 | 5 [(2,4 Dinitrophenoxy)Methyl] 1 Methyl 2 Nitro L H Imidazole And Its Pharmaceutical Use |
| LT3565806T | Novel Phenyl Derivatives |
| PT3565806T | Novel Phenyl Derivatives |
| AT1472159T | New Phenyl Derivatives |
| CN110167918B | Novel Phenyl Derivatives |
| WO2023150767A1 | Methods Of Weight Loss And Preserving Skeletal Muscle Mass |
| WO2023150759A1 | Methods Of Weight Loss In A Subject With Elevated Hba1C |
| WO2022246039A1 | Methods Of Treating Mitochondria Related Disorders |
| CA3047138A1 | 5 [(2,4 Dinitrophenoxy)Methyl] 1 Methyl 2 Nitro 1H Imidazole And Its Use In The Treatment Of Mitochondria Related Disorders |
| HK40018387A1 | Novel Phenyl Derivatives |
| AU2018205811B2 | Novel Phenyl Derivatives |
| MX388198B | New Phenyl Derivatives. |
| IL267868A | Novel Phenyl Derivatives |
| JP7090088B2 | New Phenyl Derivative |
| JP2022120118A | New Phenyl Derivative |
| KR102579648B1 | Novel Phenyl Derivatives |
| IN437208B | Novel Phenyl Derivatives |
| CL66248B | The Compound 5 [(2,4 Dinitrophenoxy)Methyl] 1 Methyl 2 Nitro 1H Imidazole; Composition; And Use To Treat Obesity, Diabetes, Among Other Diseases. |
| ZA201903808B | Novel Phenyl Derivatives |
| EA041412B1 | 5 [(2,4 Dinitrophenoxy)Methyl] 1 Methyl 2 Nitro 1H Imidazole |
| VN10034101B | Phenyl Compounds And Pharmaceuticals Containing Them |
| MY192778A | Novel Phenyl Derivatives |
| SA9785B1 | Novel Phenyl Derivatives |
| IDP000079226B | New Phenyl Derivatives |
| GEP20217227B | Novel Phenyl Derivatives |
| TW202313010A | Methods Of Treating Mitochondria Related Disorders |
| BR112019013371A2 | New Phenyl Derivatives |
| PH12019501318A1 | Novel Phenyl Derivatives |
| PE0012432019A1 | New Phenyl Derivatives |
| SG11201905121YA | Novel Phenyl Derivatives |
| CO20190006865A2 | New Phenyl Derivatives |
| US20220048865A1 | Novel Phenyl Derivatives |
| US20200399225A1 | Novel Phenyl Derivatives |
What are Rivus Pharmaceuticals’ key innovation segments?
What Technologies are Covered by Rivus Pharmaceuticals?
The chart below distributes patents filed by Rivus Pharmaceuticals